{"id":"W7117319324","doi":"10.1016/j.kint.2025.11.017","title":"A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy","year":2025,"lang":"en","type":"article","venue":"Kidney International","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia","funders":"Singapore General Hospital; Ionis Pharmaceuticals; Royal Melbourne Hospital","keywords":"Nephropathy; Complement (music); Factor H; Complement factor B; RNA; Clinical trial; Complement system; Complement factor I","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001852213,0.00202541,0.00280034,0.0005424664,0.0004982295,0.001324517,0.001138101,0.002353113,0.00728569],"category_scores_gemma":[0.001449327,0.0006294802,0.002387036,0.0003175681,0.001352712,0.001352846,0.0003901619,0.004310204,0.001019091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00112926,"about_ca_system_score_gemma":0.001436149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001425251,"about_ca_topic_score_gemma":0.003342963,"domain_scores_codex":[0.9993513,0.0002991349,0.0000206778,0.000126497,0.0000389426,0.0001633212],"domain_scores_gemma":[0.9992769,0.0001891596,0.0001041542,0.00007203357,0.00004823995,0.0003094914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9443507,0.01613187,0.0005102438,0.0004006306,0.001118051,0.0000959017,0.00008483918,0.0008336476,0.006930107,0.0002984127,0.001741621,0.02750388],"study_design_scores_gemma":[0.8993989,0.09689133,0.00118069,0.00002133061,0.0002848685,0.00005872504,0.0000234632,0.0004294287,0.0005542169,0.0001984743,0.000941002,0.00001756074],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854597,0.003609193,0.001225518,0.001600629,0.0008394736,0.002669838,0.001217005,0.0002171422,0.003161422],"genre_scores_gemma":[0.9806388,0.002210155,0.002836491,0.002473921,0.0004894148,0.003275937,0.002076553,0.00005478842,0.005944007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00728569,"threshold_uncertainty_score":0.02437305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06164509260159514,"score_gpt":0.3778111004450533,"score_spread":0.3161660078434582,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}